Will Closure Medical be a stitch in time?

Author:McMillan, Alex Frew
Position:Increase in stock prices after FDA approval of its liquid surgical glue

Sooner or later every kid takes a tumble, then a trip to the emergency room. So as far as getting stitches goes, "typically it's a matter of time," says Blount Swain, CFO of Raleigh-based Closure Medical Corp. (CLSR-NASDAQ). And for any parent trying to deal with a screaming child, it's got to be easier if the doctor pulls out a tube of glue rather than a suture needle.

That's what Closure is counting on. The Food and Drug Administration approved the company's Dermabond in late August, meaning it can start peddling the liquid surgical glue - the first of its kind in this country. Closure's stock jumped 19% that day, nearly hitting $26.

"For thousands of years they've been sewing the wound shut," Swain says. "It wasn't the perfect way, but it worked." With something that looks so revolutionary, you would think Closure's stock is a sure-fire winner. But some market watchers have started to wonder.

TAR HEEL STOCK WATCH Expensive stocks (highest price-earnings ratios among North Carolina stocks) P/E Recent 52-week Company ratio price range Konover Property Trust 346.9 $6.94 $5.75-10.00 RF Micro Devices 237.5 23.75 9.75-24.25 Insteel Industries 129.7 5.19 3.88-8.44 Applied Analytical Industries 111.2 15.50 9.00-19.13 First Charter 108.8 18.50 12.50-27.00 Winston Hotels 57.1 8.56 6.75-14.63 Collins & Aikman 53.4 6.94 5.56-10.56 Brad Ragan 47.6 39.00 32.00-39.25 Quintiles Transnational 45.3 45.25 31.00-53.50 Cree Research 44.3 25.25 10.50-29.50 Cheap stocks (lowest price-earnings ratios among North Carolina stocks) P/E Recent 52-week Company ratio price range Standard Commercia 3.6 $7.69 $6.38-18.19 Vanguard Cellular Systems 6.7 23.00 11.38-25.25 Guilford Mills 6.8 12.50 11.50-29.63 Burlington Industries 7.0 9.31 7.50-18.88 Market America 7.2 3.88 3.56-7.25 Unifi 8.5 16.88 11.50-42.25 McRae Industries 8.7 7.13 5.75-10.00 Air Transportation Holding 9.0 6.50 4.00-15.00 Culp 9.1 7.25 5.94-21.75 Midway Airlines 9.2 13.50 9.00-23.00 Jim Green, president of SunBelt Capital Management, is high on Closure but wants to see steady Dermabond sales. Thanks to a onetime licensing fee, Closure released its first quarterly profit in October, stopping a stock slide that started after the FDA approval. It closed October above $26, up from $16.81 but off its all-time high of $36.50 in fall 1997. "If they start showing earnings, it'll take off," Green says.

At $24.95 a tube, good for one wound, Dermabond is more expensive than stitches. But there's no need for an...

To continue reading